We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
+7.73%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$436M
AUM Growth
+$6.82M
Cap. Flow
+$1.23M
Cap. Flow %
0.28%
Top 10 Hldgs %
65.68%
Holding
29
New
1
Increased
9
Reduced
9
Closed
1

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$19.1M
2
IQV icon
IQVIA
IQV
+$16.2M
3
ISRG icon
Intuitive Surgical
ISRG
+$12M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$10.8M
5
OM icon
Outset Medical
OM
+$3.91M

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$14.3M
2
HUM icon
Humana
HUM
+$10.3M
3
AXNX
Axonics, Inc. Common Stock
AXNX
+$10.1M
4
BPMC
Blueprint Medicines
BPMC
+$8.62M
5
TXG icon
10x Genomics
TXG
+$8.08M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ILMN icon
1
Illumina
ILMN
$29B
$40.7M 9.34%
219,171
+96,728
+79% +$19.1M
IQV icon
2
IQVIA
IQV
$40B
$36.2M 8.31%
199,895
+73,800
+59% +$16.2M
ALNY icon
3
Alnylam Pharmaceuticals
ALNY
$29B
$32.4M 7.43%
161,716
+12,336
+8% +$2.35M
UTHR icon
4
United Therapeutics
UTHR
$22.7B
$29.5M 6.76%
140,738
-18,500
-12% -$4.14M
HUM icon
5
Humana
HUM
$46.2B
$28.7M 6.58%
59,091
-21,100
-26% -$10.3M
NTRA icon
6
Natera
NTRA
$46.4B
$26.1M 5.99%
595,994
+25,000
+4% +$1.19M
CANO
7
DELISTED
Cano Health, Inc.
CANO
$24.5M 5.63%
28,298
-9,869
-26% -$6.19M
SGEN
8
DELISTED
Seagen Inc. Common Stock
SGEN
$23.9M 5.49%
174,902
-87,600
-33% -$14.3M
ISRG icon
9
Intuitive Surgical
ISRG
$138B
$22.8M 5.23%
121,630
+56,100
+86% +$12M
DXCM icon
10
DexCom
DXCM
$33.2B
$21.4M 4.91%
265,800
+28,700
+12% +$2.43M
ARGX icon
11
argenx
ARGX
$54.2B
$21.3M 4.89%
60,300
– –
AZN icon
12
AstraZeneca
AZN
$251B
$20.7M 4.76%
188,983
-2,550
-1% -$323K
OM icon
13
Outset Medical
OM
$94M
$19.7M 4.53%
82,533
+14,602
+21% +$3.91M
INSP icon
14
Inspire Medical Systems
INSP
$1.73B
$17.8M 4.09%
100,553
+6,400
+7% +$1.29M
AMWL icon
15
American Well
AMWL
$232M
$13M 2.99%
181,586
-5,485
-3% -$480K
TNDM icon
16
Tandem Diabetes Care
TNDM
$1.57B
$9.4M 2.16%
+196,400
New +$10.8M
AGIO icon
17
Agios Pharmaceuticals
AGIO
$1.94B
$9.32M 2.14%
329,713
-246,700
-43% -$6.62M
ADPT icon
18
Adaptive Biotechnologies
ADPT
$4.09B
$8.65M 1.99%
1,214,860
– –
GH icon
19
Guardant Health
GH
$22.8B
$8.18M 1.88%
151,960
– –
AXNX
20
DELISTED
Axonics, Inc. Common Stock
AXNX
$7.79M 1.79%
110,560
-145,905
-57% -$10.1M
CMAX
21
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$5.07M 1.16%
23,825
– –
FDMT icon
22
4D Molecular Therapeutics
FDMT
$572M
$2.96M 0.68%
368,411
+106,988
+41% +$969K
TXG icon
23
10x Genomics
TXG
$7.47B
$1.4M 0.32%
49,200
-212,000
-81% -$8.08M
BEAM icon
24
Beam Therapeutics
BEAM
$2.82B
$1.38M 0.32%
28,900
– –
ARVN icon
25
Arvinas
ARVN
$585M
$1.02M 0.23%
23,000
– –
1
2

Similar funds

PIFP
Partners in Financial Planning Salem, Virginia $603M AUM 12.72% 1-Year Est. Return
IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return

Eagle Health Investments's Q3 2022 Portfolio in Review

As of Q3 2022, Eagle Health Investments held 29 positions worth $436M, up 1.6% from $429M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Eagle Health Investments's Q3 2022 filing shows 1 new, 9 increased, 9 reduced and 1 closed positions. Its largest new stake was Tandem Diabetes Care: 196,400 shares worth $9.4M. The largest sale was Seagen Inc. Common Stock, an estimated $14.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Eagle Health Investments's largest Q3 2022 buy was Tandem Diabetes Care: 196,400 shares worth $9.4M.
  • Eagle Health Investments added most to Illumina in Q3 2022, an estimated $19.1M increase.
  • Eagle Health Investments's biggest Q3 2022 reduction was Seagen Inc. Common Stock, cutting an estimated $14.3M.
  • Eagle Health Investments fully exited Blueprint Medicines in Q3 2022, selling an estimated $8.62M.
  • Eagle Health Investments's ten largest holdings make up 66% of its $436M portfolio in Q3 2022.
  • Eagle Health Investments opened 1 new position and closed 1 in Q3 2022.
  • Eagle Health Investments's portfolio value rose 1.6% quarter-over-quarter to $436M.

Based on Eagle Health Investments's 13F filing for Q3 2022, filed 14 Nov 2022.